Known targets — ChEMBL curated mechanism
ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16036373 | 1.00 | KDM4E (0.50) | KDM4ECYP3A4CA1TSHRMEN1 | |
| SCHEMBL28650936 | 1.00 | KDM4E (0.50) | KDM4ECYP3A4CA1TSHRMEN1 | |
| SCHEMBL20570963 | 0.89 | KDM4E (0.50) | KDM4ECYP3A4CA1TSHRMEN1 | |
| SCHEMBL4350805 | 0.89 | KDM4E (0.50) | KDM4ECYP3A4CA1TSHRMEN1 | |
| SCHEMBL4858286 | 0.89 | KDM4E (0.50) | KDM4ECYP3A4CA1TSHRMEN1 | |
| SCHEMBL23567016 | 0.89 | KDM4E (0.50) | KDM4ECYP3A4CA1TSHRMEN1 | |
| SCHEMBL22749162 | 0.89 | KDM4E (0.50) | KDM4ECYP3A4CA1TSHRMEN1 | |
| SCHEMBL20570026 | 0.89 | KDM4E (0.50) | KDM4ECYP3A4CA1TSHRMEN1 | |
| SCHEMBL22581617 | 0.89 | KDM4E (0.50) | KDM4ECYP3A4CA1TSHRMEN1 | |
| SCHEMBL23926540 | 0.89 | KDM4E (0.50) | KDM4ECYP3A4CA1TSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 386 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12617889-B1 | Polymers for use as anion exchange membranes | ENVISION ENERGY USA LTD. (US) | 2026-05-05 | — | — | US | claimed |
| US-20260081133-A1 | ZINC ELECTRODE FOR ALKALINE NICKEL-ZINC BATTERY AND PREPARATION METHOD THEREFOR | DONGGUAN CHAO BA BATTERIES CO LTD SHENZHEN INNOVATION CENTER (CN) | 2026-03-19 | — | — | US | claimed |
| US-20250268824-A1 | METHODS FOR MAKING REDUCED PARTICLE SIZE COMPOUNDS | TAP PHARMACEUTICALS AG (CH) | 2025-08-28 | — | — | US | claimed |
| US-20250268918-A1 | METHODS FOR MAKING REDUCED PARTICLE SIZE COMPOUNDS | TAP PHARMACEUTICALS, AG (CH) | 2025-08-28 | — | — | US | claimed |
| WO-2025027535-A1 | EXTRACTS OF SANICULA ELATA FOR USE IN TREATING PULMONARY TUBERCULOSIS | WALTER SISULU UNIVERSITY (ZA) | 2025-02-06 | — | — | WO | claimed |
| EP-4371958-A1 | DRY PREPARATIONS FOR COATING MASSES, AQUEOUS PREPARATIONS COMPRISING THE DRY PREPARATIONS, SUBSTRATES FORMED FROM THE AQUEOUS PREPARATION MASS, AND WALL STRUCTURE. BUILDING BODY COMPRISING THE SUBSTRATE | DAW SE (DE) | 2024-05-22 | — | — | EP | claimed |
| EP-4371959-A1 | DRY PREPARATIONS FOR COATING MASSES, AQUEOUS PREPARATIONS COMPRISING THE DRY PREPARATIONS, SUBSTRATES FORMED FROM THE AQUEOUS PREPARATION MASS, AND WALL STRUCTURE. BUILDING BODY COMPRISING THE SUBSTRATE | DAW SE (DE) | 2024-05-22 | — | — | EP | claimed |
| CN-117946052-A | Preparation method of 3,3' -carbonyl bis (7-diethylaminocoumarin) compound | 苏州百灵威超精细材料有限公司 | 2024-04-30 | — | — | CN | claimed |
| WO-2023091370-A1 | EXCIPIENT COMPOUNDS FOR BIOPOLYMER FORMULATIONS | COMERA LIFE SCIENCES, INC. (US) | 2023-05-25 | — | — | WO | claimed |
| US-20230078678-A1 | FORMULATIONS OF HUMAN ANTI-TSLP ANTIBODIES AND METHODS OF TREATING ATOPIC DERMATITIS | AMGEN INC. | 2023-03-16 | — | — | US | claimed |
| US-5714641-A | REACTING PHENOLIC COMPOUND WITH HYDROGEN PEROXIDE IN PRESENCE OF STRONG ACID AND BENZOPHENONE CATALYST | RHONE-POULENC CHIMIE (FR) | 1998-02-03 | — | — | US | claimed |
| US-5434317-A | Hydroxylation of phenolic compounds | RHONE-POULENC CHIMIE (FR) | 1995-07-18 | — | — | US | claimed |
| EP-0432006-B1 | Process for hydroxylating phenols and phenol ethers | RHONE POULENC CHIMIE (FR) | 1994-10-05 | — | — | EP | claimed |
| EP-0480800-B1 | Process for hydroxylating of phenolic compounds | RHONE POULENC CHIMIE (FR) | 1994-08-03 | — | — | EP | claimed |
| US-5245086-A | Hydrogen peroxide, alkali or alkaline earth metal salt of a protonic acid | RHONE-POULENC CHIMIE (FR) | 1993-09-14 | — | — | US | claimed |
| EP-0408418-B1 | METHOD OF HYDROXYLATING PHENOLS AND PHENOL ETHERS | RHONE-POULENC CHIMIE (FR) | 1993-08-25 | — | — | EP | claimed |
| US-5097078-A | Using hydrogen peroxide | RHONE-POULENC CHIMIE (FR) | 1992-03-17 | — | — | US | claimed |
| EP-0187715-B1 | PROCESS FOR COAGULATING POLYMER LATICES AND POLYMERIC ARTICLES PREPARED THEREBY | ROHM AND HAAS COMPANY (US) | 1991-09-11 | — | — | EP | claimed |
| US-4602083-A | AQUEOUS POLYMER LATEX USING AQUEOUS SOLUTION OF GROUP 2 METAL SALT | ROHM AND HAAS COMPANY (US) | 1986-07-22 | — | — | US | claimed |
| EP-0187715-A2 | Process for coagulating polymer latices and polymeric articles prepared thereby | ROHM AND HAAS COMPANY (US) | 1986-07-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250268918-A1 | METHODS FOR MAKING REDUCED PARTICLE SIZE COMPOUNDS | NR3C2, DHCR7, HDAC10 | KDM4E 2377/4885CYP3A4 956/4885CA1 2889/4885 |
| US-20230078678-A1 | FORMULATIONS OF HUMAN ANTI-TSLP ANTIBODIES AND METHODS OF TREATING ATOPIC DERMATITIS | TSLP, IL5, ORAI1 | KDM4E 4278/4885CYP3A4 4776/4885CA1 1493/4885 |
| US-20260081133-A1 | ZINC ELECTRODE FOR ALKALINE NICKEL-ZINC BATTERY AND PREPARATION METHOD THEREFOR | SLC39A11, SLC30A7, SLC39A7 | KDM4E 3664/4885CYP3A4 3714/4885CA1 8/4885 |
| US-20250268824-A1 | METHODS FOR MAKING REDUCED PARTICLE SIZE COMPOUNDS | NR3C2, DHCR7, HDAC10 | KDM4E 1931/4885CYP3A4 443/4885CA1 2927/4885 |
| US-12617889-B1 | Polymers for use as anion exchange membranes | KCNN3, KCNJ1, KCNH3 | KDM4E 891/4885CYP3A4 3590/4885CA1 267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.